sulfadiazine has been researched along with Waldenstrom Macroglobulinemia in 1 studies
Sulfadiazine: One of the short-acting SULFONAMIDES used in combination with PYRIMETHAMINE to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.
sulfadiazine : A sulfonamide consisting of pyrimidine with a 4-aminobenzenesulfonamido group at the 2-position.
diazine : The parent structure of the diazines.
Waldenstrom Macroglobulinemia: A lymphoproliferative disorder characterized by pleomorphic B-LYMPHOCYTES including PLASMA CELLS, with increased levels of monoclonal serum IMMUNOGLOBULIN M. There is lymphoplasmacytic cells infiltration into bone marrow and often other tissues, also known as lymphoplasmacytic lymphoma. Clinical features include ANEMIA; HEMORRHAGES; and hyperviscosity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Olmos Soto, S | 1 |
| Reus Bañuls, S | 1 |
| Mora Castera, E | 1 |
| Villarubia Lor, MB | 1 |
1 other study available for sulfadiazine and Waldenstrom Macroglobulinemia
| Article | Year |
|---|---|
[Cerebral toxoplasmosis in a patient with Waldenström's macroglobulinemia].
Topics: Aged; Antiprotozoal Agents; Biopsy; Cross Infection; Drug Therapy, Combination; Fatal Outcome; Human | 2014 |